ArticleYonsei medical journal2020

Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection.

Eun Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.